A Study to Evaluate the Safety and Immunogenicity of A/California/7/2009 (H1N1)V-like Vaccines GSK2340274A and GSK2340273A in Children 6 Months to Less Than 9 Years of Age.
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; AS03A; AS03B
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 01 Aug 2012 Results published in the Pediatric Infectious Disease Journal.
- 03 Dec 2010 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 03 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History